Nine Biopharm
PrivateLast Round
Series A
Dec 20, 2021
Total Funding Raised
$6.75M
Company Overview
Nine Biopharm is a biomaterials company that develops peptide-based materials for pharmaceuticals, medical devices, and cosmetics using a proprietary computer simulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Biopharm Comparables
Compare Nine Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaResearch | 76% | |
| Caregen Co., Ltd. | 75% | |
| Daewoong Pharmaceutical | 71% |
Nine Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2021 |
Nine Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capstone Partners | Series A |
| Korea Asset Investment Securities | Series A |
| Laplace Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 20, 2021
$7M round led by Korea Asset Investment Securities.
Nine Biopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nine Biopharm's valuation, stock price, and market status.
Is Nine Biopharm a public or private company?
Nine Biopharm is a private company.
What is the current stock price of Nine Biopharm?
Nine Biopharm is a private company with no public stock price. No recent secondary market data is available.
How much is Nine Biopharm worth (valuation)?
Valuation information for Nine Biopharm is not publicly available.
Can I buy Nine Biopharm stock?
Nine Biopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nine Biopharm's last funding round?
Nine Biopharm's most recent funding round was Series A on December 20, 2021.
Who are the main investors in Nine Biopharm?
Key investors in Nine Biopharm include Capstone Partners, Korea Asset Investment Securities, Laplace Partners.
Will Nine Biopharm IPO soon?
No public IPO plans have been announced for Nine Biopharm.
How can I track Nine Biopharm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nine Biopharm's secondary market activity and sign up for updates.